Botox-maker Allergan Inc. announced the second-quarter profit early Friday, the figures were substantially higher, attributable in part to the company’s cost-cutting measures.
Allergan registered its second-quarter earnings rose to $176.1 million from $143.4 million in the year-earlier period.
Excluding various items, Allergan would have posted adjusted earnings of 75 cents a share compared to the year-earlier 63 cents.
Analysts polled by FactSet were expecting earnings of 67 cents a share, on average.
Revenue for the quarter slipped to $1.13 billion from $1.17 billion. Excluding the impact of a strong U.S. dollar overseas, sales would have been up 2.2%.
The Irvine, Calif.-based company also issued its financial forecast. Allergan now sees adjusted earnings of 67 cents to 69 cents a share for the third quarter and $2.71 to $2.75 a share for the full year.